Match each clinical adjustment in diagnostic testing strategy or patient population with its direct mathematical consequence on the test's performance characteristics.
- Applying a screening test to a high-risk specialty clinic rather than a low-risk general population (increasing disease prevalence).Increases the test's Positive Predictive Value (PPV) and decreases its Negative Predictive Value (NPV).
- Applying a screening test to an asymptomatic general population rather than symptomatic patients (decreasing disease prevalence).Increases the test's Negative Predictive Value (NPV) and decreases its Positive Predictive Value (PPV).
- Lowering the numerical cutoff threshold required for a biomarker test to be considered 'positive'.Increases the test's Sensitivity while decreasing its Specificity.
- Raising the numerical cutoff threshold required for a biomarker test to be considered 'positive'.Increases the test's Specificity while decreasing its Sensitivity.
Cevap
Prevalence shifts alter predictive values (PPV and NPV) directly, while cutoff adjustments alter intrinsic test characteristics (Sensitivity and Specificity) inversely.
The core relationships in diagnostic testing dictate that prevalence directly affects predictive values (PPV and NPV) but not sensitivity or specificity. Conversely, altering the diagnostic cutoff threshold forces a direct trade-off between sensitivity (true positive rate) and specificity (true negative rate), which subsequently impacts predictive values.
Adım Adım Çözüm
Anahtar Kavram
Impact of Prevalence and Cutoffs on Diagnostic Test Characteristics